Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience

Articolo

Data di Pubblicazione:

2019

Citazione:

Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience / Pouillon, L; Baumann, C; Rousseau, H; Choukour, M; Andrianjafy, C; Danese, S; Peyrin-Biroulet, L. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 25:5(2019), pp. 945-954. [10.1093/ibd/izy322]

Tipologia CRIS:

1.1 Articolo in rivista

Elenco autori:

Pouillon, L; Baumann, C; Rousseau, H; Choukour, M; Andrianjafy, C; Danese, S; Peyrin-Biroulet, L

Autori di Ateneo:

DANESE SILVIO

Link alla scheda completa:

https://iris.unisr.it/handle/20.500.11768/119883

Pubblicato in:

INFLAMMATORY BOWEL DISEASES

Journal